摘要:
A catalyst component for olefin polymerization is disclosed, which comprises a reaction product of the following components: (1) a spheric carrier; (2) a titanium compound; and optionally, (3) an electron donor, wherein the spheric carrier comprises a reaction product of at least the following components: (a) a magnesium halide represented by a general formula of MgX2-nRn, wherein X is independently chloride or bromide, R is a C1-C14 alkyl, a C6-C14 aryl, a C1-C14 alkoxy, or a C6-C14 aryloxy, and n is 0 or 1; (b) an alcohol compound; and (c) an epoxy compound represented by a general formula (I), wherein R2 and R3 are independently hydrogen, a C1-C5 linear or branched alkyl, or a C1-C5 linear or branched haloalkyl. When the catalyst of the invention is used in olefin polymerization, in particular in propylene polymerization, at least one of the following desired effects can be achieved: high polymerization activity of catalyst, high stereospecificity of catalyst, good hydrogen response of catalyst, high stereoregularity of polymer having high melt index, and low content of polymer fines.
摘要:
A magnesium halide adduct is provided, comprising at least one compound of the formula MgXY, at least one compound of the formula ROH, methanol, at least one modifying agent chosen from DOE and o-hydroxy benzoates, and optionally water. Also provided herein are a catalyst component comprising the magnesium halide adduct, a catalyst for olefin polymerization comprising the catalyst component; the respective processes for preparing the magnesium halide adduct and the catalyst component; use of the magnesium halide adduct for preparing the catalyst component, use of the catalyst component in a catalyst for olefin polymerization and use of the catalyst in olefin polymerization; and a process of olefin polymerization.
摘要:
The disclosure provides novel molecules related to growth and differentiation factor-8 (GDF-8), in particular mouse and humanized antibodies, and antibody fragments, including those that inhibit GDF-8 activity and signaling in vitro and/or in vivo. The disclosure also provides methods for diagnosing, treating, ameliorating, preventing, prognosing, or monitoring degenerative orders of muscle, bone, and insulin metabolism, etc., in particular amyotrophic lateral sclerosis (ALS). In addition, the disclosure provides pharmaceutical compositions for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention.
摘要:
The disclosure provides novel molecules related to growth and differentiation factor-8 (GDF-8), in particular mouse and humanized antibodies, and antibody fragments, including those that inhibit GDF-8 activity and signaling in vitro and/or in vivo. The disclosure also provides methods for diagnosing, treating, ameliorating, preventing, prognosing, or monitoring degenerative orders of muscle, bone, and insulin metabolism, etc., in particular amyotrophic lateral sclerosis (ALS). In addition, the disclosure provides pharmaceutical compositions for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention.
摘要:
Methods, systems, and apparatuses for wafer-level integrated circuit (IC) packages are described. An IC package includes an IC chip, an insulating layer on the IC chip, a plurality of vias, a plurality of routing interconnects, and a plurality of bump interconnects. The IC chip has a plurality of terminals configured in an array on a surface of the IC chip. A plurality of vias through the insulating layer provide access to the plurality of terminals. Each of the plurality of routing interconnects has a first portion and a second portion. The first portion of each routing interconnect is in contact with a respective terminal of the plurality of terminals though a respective via, and the second portion of each routing interconnect extends over the insulating layer. Each bump interconnect of the plurality of bump interconnects is connected to the second portion of a respective routing interconnect of the plurality of routing interconnects.
摘要:
Agents (e.g., antibodies and fragments thereof) that bind specifically to IL 13 and modulate the ability of IL-13 to interact with IL-13 receptors and signaling mediators are disclosed.
摘要:
This application relates to antibodies, e.g., humanized antibodies, and antigen-binding fragments thereof, that bind to interleukin-13 (IL-13), in particular, human IL-13, and their uses in regulating immune responses mediated by IL-13. The antibodies disclosed herein are useful in diagnosing, preventing, and/or treating a subject, e.g., a human patient, one or more IL-13-associated disorders, e.g., respiratory disorders (e.g., asthma); atopic disorders (e.g., allergic rhinitis); inflammatory and/or autoimmune conditions of the skin (e.g., atopic dermatitis), and gastrointestinal organs (e.g., inflammatory bowel diseases (IBD)), as well as fibrotic and cancerous disorders.
摘要:
This device for giving and controlling a vehicle U-turn signal comprises a U-turn signal indicator (1) and a control circuit. The U-turn signal indicator (1) can consist of an array of LEDs which makes a loop circuit with an arrow. One can be mounted on the front plate (2) of a vehicle, and another one can be mounted on the back plate. The control circuit consists of a rectifier, a first integrator, a second integrator, a counter, a switching transistor, and a relay. The output of the rectifier is connected to the inputs of the first and second integrators of which the outputs are connected to the CLK and to the RST of the counter respectively. The outputs of the counter and the rectifier are connected to the inputs of the NAND which controls the on or off working state of the switching transistor and the relay, to activate the U-turn indicator. The input of the rectifier is connected to the turn signal pulses of a vehicle. When certain pulse patterns are generated, the U-turn signal indicator is activated.
摘要:
One embodiment relates to an integrated circuit which includes a method of dynamically adjusting a receive buffer in an integrated circuit. A fixed-size buffer circuit of the receive buffer is used to buffer data received by way of a serial interface circuit. The performance of the serial interface circuit are monitored. The receive buffer is dynamically extended based on said performance. Other embodiments, aspects, and features are also disclosed.
摘要:
A catalyst component for olefin polymerization is disclosed, which comprises at least one diol ester type electron donor compound (a) and at least one diether type electron donor compound (b) among others, wherein the molar ratio of a to b is 0.55-50. A preparation method of the catalyst component, a catalyst comprising the catalyst component, and an olefin polymerization method using the catalyst which can especially be used for preparation of polypropylenes of low ash contents are also disclosed.